Home What we do Our Business Units Advisory


Depth by design: Empowering decisions in Pharma and Life Sciences.

Depth by design

Precisely the expertise you need, when you need it.

Inizio Advisory has deep health and life sciences knowledge and therapeutic area expertise to help clients make better decisions to create long-term value for their patients.  Our connected solutions provide a fresh perspective and actionable strategic insights across the whole product lifecycle.

Designed to Make a Difference.

Our carefully curated and fully connected end-to-end services offer tailored services to your organization and product, wherever you are in your journey. From deep specialist insights through to impactful product launch, our services help turn your complex science into actionable impact that improves patient outcomes.

We help clients across:

  • Strategy development, transformation and execution
  • Portfolio licensing and development
  • Product launch
  • Established product and franchise strategy
  • Health economics and outcomes research (HEOR)
  • Value, pricing and access
  • Market insights
  • Competitive intelligence
  • Strategic benchmarking

Designed to make a difference

Our Advisory Businesses


We help our clients transform by bridging the gap between strategy & execution.


Driving healthier business results across the interwoven sectors of healthcare, Vynamic’s team of accomplished leaders with consulting and industry expertise helps clients transform their business through actionable strategy, operational intelligence, and healthy culture. While Vynamic takes pride in what they deliver, it’s how they do it that makes them unlike any other consulting partner.

Research Partnership

We help clients understand their market & brands better through our strategic insights.


As the market research specialist of the ecosystem, Research Partnership combines evidence with therapeutic and market expertise to bridge the gap between research and consultancy. We collaborate with clients from the global pharmaceutical, MedTech and biotech industries to deliver fresh insights and strategic recommendations that elevate healthcare brands and help them thrive in a complex and challenging environment.



We help clients make better strategic decisions for their products and portfolios.


Strategically solving the most complex and dynamic problems facing the global life science industry today, Putnam specializes in new product strategy, portfolio licensing and development strategy, value, pricing, and access strategy, established product and franchise strategy, enterprise strategy, and medical and scientific affairs strategy.


We help clients align their strategy with execution to accelerate growth.


In a rapidly evolving market landscape, STEM can help Commercial and Medical Affairs leaders make informed decisions to optimize strategy execution at the customer interface. STEM partners with 29 of the top 30 large pharma companies and emerging biotechs to further accelerate brand performance. Our unique observational methodology and proprietary benchmark database, combined with our trusted advisors, enable STEM to provide our clients with strategic insights and actionable recommendations.


Our Leadership Team

Colin Stanley

Global President,
Inizio Advisory

Dermot Kenny


Jeff Dill

CEO, Vynamic

Mark Jeffery

CEO, Research Partnership

Mary Assimakopoulos

CEO, Research Partnership

Remco op den Kelder

CEO, Putnam

Martin Curry

CFO, Inizio Advisory

Emer Jameson

Vice President HR, Inizio Advisory

Michele Quinn

Head of Branding and Marketing, Inizio Advisory

Emma Dennehy

Vice President, Strategy and Key Initiatives, Inizio Advisory

Get in touch

Tell us what you want to achieve and the challenges you face, and we’ll build a multidisciplinary team of experts to deliver everything you need.